IP Library Granted Patent US 11,925,560
Granted Patent B2
US 11,925,560 · App. 16/850,246 · Granted Mar 12, 2024

Device implantable in a human body and production method thereof

Inventor: Augusto Magagnoli (Cervia, IT)
A61F2/30724A61F2/3859A61F2002/30677A61F2002/30726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,925,560
App. No.
16/850,246
Granted
Mar 12, 2024
Kind
B2
Abstract

A device implantable in a human body comprising a first component, or main support component, delimiting a plurality of openings, and a second component disposed on a surface of the main support component.

Claims (43)

1. An implantable device in a human body consisting of:

a first component or main support component delimiting a plurality of through holes; and

a second component applied on at least one outer surface of the main support component,

the second component comprising a dough applied and hardened or solidified on the at least one outer surface and at least in part within the holes,

the dough including a matrix of at least one first compound and at least one pharmaceutical or medical substance dispersed in the matrix,

the second component being a component that stiffens or increases a resistance of the main component, and/or a component adapted to convey, in use, the at least one pharmaceutical or medical substance from the implantable device to an outside thereof and into an implant site,

wherein the main support component comprises a plurality of reference elements that define an application area of the dough on the at least one outer surface,

wherein the reference elements comprise pegs extending, spaced from each other, from the at least one outer surface, the dough entirely covering the pegs and extending therebetween,

wherein the implantable device comprises no closing component,

wherein the main support component and the second component constitute an assembly implantable in the human body,

wherein the pegs are distributed on the at least one outer surface, so that an area defined by a perimeter or line passing through the outermost periphery of the plurality of reference elements is at least 60% of the at least one outer surface,

wherein the main support component includes a raised perimeter or delimitation edge of an application area of the second component on the at least one outer surface of the main support component, and

wherein the second component is applied so as to be flush or in line with, and not recessed within, an end of the raised perimeter or delimitation edge, and to fill all spaces between the pegs.

2. The implantable device according to claim 1 , wherein the holes have a passage section between 0.05 and 10 mm.

3. The implantable device according to claim 2 , wherein the holes are at a distance from each other of 0.1 to 5 mm.

4. The implantable device according to claim 1 , wherein the main support component has a thickness of 0.1 to 100 mm.

5. The implantable device according to claim 1 , wherein the second component has a thickness of 0.1 mm to 100 mm.

6. The implantable device according to claim 1 , wherein the main component and the second component define all outer surfaces of the implantable device, the outer surfaces being adapted to come into contact with respective parts of the human body.

7. The implantable device according to claim 1 , wherein the at least one outer surface delimits a concave area configured to house the second component.

8. The implantable device according to claim 7 , wherein the concave area has a height of 5 to 200 mm.

9. The implantable device according to claim 1 , wherein the implantable device is configured as a joint spacer, a prosthesis, or a component of a joint spacer or of a prosthesis.

10. The implantable device according to claim 9 , wherein the main support component has substantially a same final shape as the implantable device, with a concave area and/or a convex surface enveloped, in whole or in part, within the second component.

11. The implantable device according to claim 1 , wherein the main component is made of a biologically compatible material.

12. The implantable device according to claim 1 , wherein the first compound is selected from the group consisting of bone cement, inorganic hydraulic cement, and ceramic cement.

13. The implantable device according to claim 1 , wherein the pharmaceutical or medical substance comprises at least one antibiotic.

14. An implantable device in a human body consisting of:

a first component or main support component delimiting a plurality of through holes; and

a second component applied on at least one outer surface of the main support component,

the second component comprising a dough applied and hardened or solidified on the at least one outer surface and at least in part within the holes,

the dough including a matrix of at least one first compound and at least one pharmaceutical or medical substance dispersed in the matrix,

the second component being a component that stiffens or increases a resistance of the main component, and/or a component adapted to convey, in use, the at least one pharmaceutical or medical substance from the implantable device to an outside thereof and into an implant site,

wherein the main support component comprises a plurality of reference elements that define an application area of the dough on the at least one outer surface,

wherein the reference elements comprise pegs extending, spaced from each other, from the at least one outer surface, the dough covering the pegs and extending therebetween,

wherein the implantable device comprises no closing component,

wherein the main support component and the second component constitute an assembly implantable in the human body,

wherein the pegs are distributed on the at least one outer surface, so that an area defined by a perimeter or line passing through the outermost periphery of the plurality of reference elements is at least 60% of the at least one outer surface, and

wherein the main support component includes at least two opposing outer surfaces, and wherein the second component is applied on both of the at least two opposing outer surfaces.

15. The implantable device according to claim 14 , wherein the second component completely envelopes the main support component.

16. A method of obtaining a device implantable in a human body, comprising a first component or main support component delimiting a plurality of through holes and a second component applied on at least one outer surface of the main support component, the second component comprising a dough applied and hardened or solidified on the at least one outer surface and at least in part within the holes, the dough including a matrix comprising a first compound and a pharmaceutical or medical substance dispersed in the matrix, the second component being a component that stiffens or increase a resistance of the main support component and/or a component adapted to convey, in use, the pharmaceutical or medical substance from the device to an outside thereof and in an implant site, wherein the main support component comprises a plurality of reference elements that define an application area of the dough on the at least one outer surface, wherein the reference elements comprise pegs extending, spaced from each other, from the at least one outer surface, the first component having a raised perimeter or delimitation edge of an application area of the second component on the at least one outer surface of the main component, the method comprising the steps of:

providing the main support component;

preparing the dough including the matrix of the first compound and the pharmaceutical or medical substance dispersed in the matrix;

applying the dough on at least one outer surface of the main support component before implanting the device in the human body to entirely cover the pegs and extend and fill all spaces therebetween; and

causing to, or letting, the dough harden or solidify.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2024
From: COSSINGTON LIMITED
To: TECRES S.P.A.
Reel/Frame 067739/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2020
From: MAGAGNOLI, AUGUSTO
To: COSSINGTON LIMITED
Reel/Frame 052680/0273 →
Priority Claims (1)
IT 2015000065 · Feb 16, 2015 · national
Continuity (2)
Continuation In Part 14701398 · Apr 30, 2015
Related Publication 20200315804A1 · Oct 8, 2020